Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Pressure Reduction Induced by Continuous Positive Airway Pressure (CPAP) in Sleep Apnea Patients at High Cardiovascular Risk : A Randomized Controlled Trial Comparing Usual CPAP Care Versus a Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform

NCT01505959 is registered in ClinicalTrials.gov with Fédération Française de Pneumologie as lead sponsor.

NCT NCT01505959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Pressure Reduction Induced by Continuous Positive Airway Pressure (CPAP) in Sleep Apnea Patients at High Cardiovascular Risk : A Randomized Controlled Trial Comparing Usual CPAP Care Versus a Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform
Lead sponsor
Fédération Française de Pneumologie
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2013
Completion date
December 31, 2014
Enrollment
936 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

high cardiovascular risk, sleep apnea syndromes